🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in the Netherlands / NCT06330350
Recruiting Observational

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

NCT06330350 · tracked via the Priya Life Science Netherlands tracker
Phase
Observational
Started
2024-01-01
Last updated
2025-05-18

Condition(s) studied

Quality of LifeIchthyosisPalmoplantar KeratosesEpidermolysis BullosaEctodermal DysplasiaBasal Cell Nevus SyndromeBirt-Hogg-Dube SyndromeTuberous SclerosisCutis LaxaAlbinism

Investigational drug(s) / intervention(s)

Qualitative interview

Qualitative interview: Gaining insight into the perspectives of patients with genodermatoses and their partners, and health care professionals concerning reproductive decision-making and counselling.

Study summary

The goal of this observational study is to understand the perspectives and needs of patients with genodermatoses and their partners who wish to have children, regarding their decision-making process and their consideration of reproductive options. Additionally, the investigators aim to investigate the level of knowledge and perspectives of healthcare professionals (such as clinical geneticists, dermatologists and other clinicians involved), and want to explore to what extent patients and their partners are well informed about these reproductive options. To achieve this, the investigators will conduct individual semi-structured qualitative interviews with participants affected by genodermatoses (and their partners) and with healthcare professionals.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients with genodermatosis (i.e, keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, other genodermatoses) and a desire to have children, with if applicable his or her partner with a desire to have children * Patients with clinically and molecularly confirmed variant of a genodermatosis * Health care professionals involved with the care of genodermatology patients (e.g. clinical geneticists, dermatologists) Exclusion Criteria: * Not being able to communicate verbally in Dutch or English

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Maastricht University Medical Center Maastricht Limburg Recruiting

More Maastricht University Medical Center trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06330350 on ClinicalTrials.gov ↗ ← All trials in the Netherlands